Watson 370 10 mg (Loxapine 10 mg)
Pill imprint Watson 370 10 mg has been identified as Loxapine succinate 10 mg.
Loxapine is used in the treatment of schizophrenia; agitated state; agitation and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- Watson 370 10 mg
- Strength:
- 10 mg
- Color:
- White & Yellow
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-0370
- Inactive Ingredients:
- lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0901 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about loxapine
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
